The forecast for leukemia mortality in the U.S. remains steady from 2024 to 2028, with a rate of 7.1 deaths per 100,000 persons. As of 2023, actual data had already positioned this figure around the same value, showing no projected year-on-year variation over the subsequent five years. This consistent pattern suggests a CAGR of 0% from 2024 through 2028.

Future trends to watch for:

Advancements in leukemia treatment and early detection could alter mortality forecasts positively.
Policy changes in healthcare access might impact future rates.
Ongoing research into genetic and environmental causes could influence prevention strategies.